Article
A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma
17 May 2010
Abstract excerpt
Despite improvement in the treatment of advanced classical Hodgkin lymphoma, approximately 30% of patients relapse or die as result of the disease. Current predictive systems, determined by clinical and analytical parameters, fail to identify these high-risk patients accurately. We took a multistep approach to design a quantitative reverse-transcription polymerase chain reaction assay to be applied to routine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
